Cannabidiol Study |
We appreciate the 3 minutes of your time that you are giving us to complete this survey. Gen Re is a well-respected global reinsurance company, leading the research into the now legalised Cannabidiol* in South Africa.
We simply want to understand why and how individuals choose to use it as a form of treatment.
All your answers will be anonymous to Gen Re. There is a voluntary lucky draw, where you stand a chance to win a Takealot Voucher to the value of R 1000. If you would like to participate in the draw, we would need your email address at the end of the Survey. Gen Re staff will only have access to the questionnaire answers and not your email address. Your email address will be separated from the answers and sent directly to an independent third party who will do the lucky draw and communicate your winnings to you.
*Quick background
In September last year South Africa’s constitutional court ruled the private use of small amounts of cannabis for personal use as legal. Further changes to legislation have now been made and in May 2019, when South Africa's Department of Health removed Cannabidiol (CBD), the non – psychoactive compound of the marijuana plant, from the country's Schedule 7 list of highly controlled drugs. This change now allows for the legal sale of CBD products made in accordance with the government's specifications.
We simply want to understand why and how individuals choose to use it as a form of treatment.
All your answers will be anonymous to Gen Re. There is a voluntary lucky draw, where you stand a chance to win a Takealot Voucher to the value of R 1000. If you would like to participate in the draw, we would need your email address at the end of the Survey. Gen Re staff will only have access to the questionnaire answers and not your email address. Your email address will be separated from the answers and sent directly to an independent third party who will do the lucky draw and communicate your winnings to you.
*Quick background
In September last year South Africa’s constitutional court ruled the private use of small amounts of cannabis for personal use as legal. Further changes to legislation have now been made and in May 2019, when South Africa's Department of Health removed Cannabidiol (CBD), the non – psychoactive compound of the marijuana plant, from the country's Schedule 7 list of highly controlled drugs. This change now allows for the legal sale of CBD products made in accordance with the government's specifications.
Okay! Let's get started!